CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 439 filers reported holding CRISPR THERAPEUTICS AG in Q2 2022. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $372,000 | +24.8% | 5,934 | +50.8% | 0.00% | – |
Q4 2021 | $298,000 | -29.7% | 3,934 | +4.0% | 0.00% | – |
Q3 2021 | $424,000 | -30.8% | 3,784 | 0.0% | 0.00% | -100.0% |
Q2 2021 | $613,000 | +4.1% | 3,784 | -21.7% | 0.00% | 0.0% |
Q1 2021 | $589,000 | -51.0% | 4,834 | -38.4% | 0.00% | 0.0% |
Q4 2020 | $1,201,000 | +445.9% | 7,844 | +197.8% | 0.00% | – |
Q3 2020 | $220,000 | +13.4% | 2,634 | 0.0% | 0.00% | – |
Q2 2020 | $194,000 | +73.2% | 2,634 | 0.0% | 0.00% | – |
Q1 2020 | $112,000 | -67.4% | 2,634 | -53.3% | 0.00% | – |
Q4 2019 | $344,000 | +224.5% | 5,645 | +118.5% | 0.00% | – |
Q3 2019 | $106,000 | +5.0% | 2,584 | +21.1% | 0.00% | – |
Q2 2019 | $101,000 | +21.7% | 2,134 | -8.6% | 0.00% | – |
Q1 2019 | $83,000 | +16.9% | 2,334 | -6.0% | 0.00% | – |
Q4 2018 | $71,000 | -77.5% | 2,484 | -65.0% | 0.00% | – |
Q3 2018 | $315,000 | -44.1% | 7,103 | -25.9% | 0.00% | -100.0% |
Q2 2018 | $564,000 | +27.3% | 9,591 | -1.0% | 0.00% | 0.0% |
Q1 2018 | $443,000 | +119.3% | 9,691 | +12.9% | 0.00% | – |
Q4 2017 | $202,000 | -41.3% | 8,584 | -55.5% | 0.00% | – |
Q3 2017 | $344,000 | – | 19,276 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |